Acadia Pharmaceuticals (ACAD) Research & Development (2010 - 2026)
Acadia Pharmaceuticals' Research & Development was $81.56 million in Q2 2026, up 4.6% from $77.95 million a year earlier and up 6.1% from the prior quarter.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Research & Development (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Acadia Pharmaceuticals' Research & Development was $331.01 million through Jun 30, 2026, up 2.3% year-over-year; for FY2025, it was $328.8 million, up 8.4% from FY2024.
- Research & Development shows a five-year compound annual growth rate of 0.6% (FY2020 to FY2025).
- In earlier years, Research & Development was $303.25 million in FY2024 (-13.8%), $351.62 million in FY2023 (-2.8%), $361.58 million in FY2022 (+51.0%) and $239.42 million in FY2021 (-25.0%).
- Quarterly Research & Development has moved between $58.57 million (Q3 2021) and $156.96 million (Q3 2023) over five years.
- Compared with a year earlier, Research & Development was higher in five of the last eight quarters, with growth averaging 5.7%.
- The best year-over-year quarter for Research & Development over five years was Q1 2022 (growth of 126.2%); the worst was Q3 2024 (a decline of 57.6%).
- Per Business Quant data, ACAD's Research & Development in the three quarters before Q2 2026 was $76.87 million (Q1 2026), $84.76 million (Q4 2025) and $87.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Acadia Pharmaceuticals | 3.49 Bn | 19.20 Mn | 279.64 Mn | 81.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 81.56 Mn |
| Mar 31, 2026 | 76.87 Mn |
| Dec 31, 2025 | 84.76 Mn |
| Sep 30, 2025 | 87.83 Mn |
| Jun 30, 2025 | 77.95 Mn |
| Mar 31, 2025 | 78.27 Mn |
| Dec 31, 2024 | 100.73 Mn |
| Sep 30, 2024 | 66.61 Mn |
| Jun 30, 2024 | 76.23 Mn |
| Mar 31, 2024 | 59.68 Mn |
| Dec 31, 2023 | 66.74 Mn |
| Sep 30, 2023 | 156.96 Mn |
| Jun 30, 2023 | 58.77 Mn |
| Mar 31, 2023 | 69.14 Mn |
| Dec 31, 2022 | 75.74 Mn |
| Sep 30, 2022 | 81.34 Mn |
| Jun 30, 2022 | 75.65 Mn |
| Mar 31, 2022 | 128.86 Mn |
| Dec 31, 2021 | 66.94 Mn |
| Sep 30, 2021 | 58.57 Mn |
API Access
Acadia Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();